Appetite control and glycaemia reduction in overweight subjects treated with a combination of two highly standardized extracts from phaseolus vulgaris and Cynara scolymus

Phytotherapy Research

Volumn 25, Issue 9, 2011, Pages 1275-1282

  Rondanelli, Mariangela ^a   Giacosa, Attilio ^b   Orsini, Francesca ^a   Opizzi, Annalisa ^a   Villani, Simona ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Policlinico di Monza ^*  (Italy)

Author keywords

Cynara scolymus; dietary supplement; glucose; overweight; Phaseolus vulgaris; satiation

Indexed keywords

CYNARA SCOLYMUS EXTRACT; GLUCOSE; LIPID; PHASEOLUS VULGARIS EXTRACT; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICHOKE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUNGER; MALE; OBESITY; PHASEOLUS VULGARIS; PSYCHODYNAMICS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SATIETY; THREE FACTOR EATING QUESTIONNAIRE; TREATMENT DURATION; ANALYSIS; APPETITE; CHEMISTRY; DRUG EFFECTS; FOOD INTAKE; MIDDLE AGED; OVERWEIGHT; PHASEOLUS;

CYNARA SCOLYMUS; PHASEOLUS VULGARIS;

ADULT; APPETITE; APPETITE REGULATION; BLOOD GLUCOSE; CYNARA SCOLYMUS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OVERWEIGHT; PHASEOLUS; PLANT EXTRACTS; SATIATION;

EID: 80052276434     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3425     Document Type: Article

References (30)

1. American Psychiatric Association. 1994. Mood disorders. In Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association: Washington, DC, 317-345.
2. Arion WJ, Canfield WK, Ramos FC, et al., 1997. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 339: 315-322. (Pubitemid 27199976)
3. Baintner K, Kiss P, Pfüller U, Bardocz S, Pusztai A,. 2003. Effect of orally and intraperitoneally administered plant lectins on food consumption of rats. Acta Physiol Hung 90: 97-107. (Pubitemid 36850869)
4. Blumenthal M, Goldner A, Brinkmann J,. 2000. Artichoke leaf. In Herbal Medicine: Expanded Commission E Monographs, Blumenthal M, Goldnerg A, Brinkmann J, (eds., Herbal Medicine: Expanded Commission E Monographs,). Integrative Medicine Communications: Boston, MA, 10-210-12.
5. Boivin M, Zinsmeister AR, Go VL, DiMagno EP,. 1987. Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans. Mayo Clin Proc 2: 249-255. (Pubitemid 17052822)
6. Brown WV, Fujioka K, Wilson PW, Woodworth KA,. 2009. Obesity: why be concerned? Am J Med 122: S4-S11.
7. Brugge WR, Rosenfeld MS,. 1987. Impairment of starch absorption by a potent amylase inhibitor. Am J Gastroenterol 82: 718-722. (Pubitemid 17145096)
8. Bundy R, Walker AF, Middleton RW, Wallis C, Simpson HC,. 2008. Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial. Phytomedicine 15: 668-675.
9. Celleno L, Tolaini MV, D'Amore A, Perricone NV, Preuss HG,. 2007. A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci 24: 45-52. (Pubitemid 46168687)
10. Fantini N, Cabras C, Lobina C, et al., 2009. Reducing effect of a Phaseolus vulgaris dry extract on food intake, body weight, and glycemia in rats. J Agric Food Chem 57: 9316-9323.
11. Fantini N, Colombo G, Giori A, et al., 2011. Evidence of glycemia-lowering effect by a Cynara scolymus L. extract in normal and obese rats. Phytother Res 3: 463-466.
12. Frisancho AR,. 1984. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr 40: 808-819. (Pubitemid 14014416)
13. Gebhardt R,. 2002. Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pretreatment. Phytother Res 16: 368-372. (Pubitemid 34704631)
14. Gormally J, Black S, Daston S, Rardin D,. 1982. The assessment of binge eating severity among obese persons. Addict Behav 7: 47-55. (Pubitemid 12131037)
15. Haber GB, Heaton KW, Murphy D, Burroughs LF,. 1977. Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose and serum insulin. Lancet 2: 679-682. (Pubitemid 8187278)
16. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H,. 1996. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diab Care 19: 1138-1141. (Pubitemid 26334266)
17. Helmstädter A,. 2007. Antidiabetic drugs used in Europe prior to the discovery of insulin. Pharmazie 62: 717-720. (Pubitemid 47515180)
18. Hernandez-Galicia E, Aguilar-Contreras A, Aguilar-Santamaria L, et al., 2002. Studies on hypoglycemic activity of Mexican medicinal plants. Proc West Pharmacol Soc 45: 118-124. (Pubitemid 35253064)
19. Jain NK, Boivin M, Zinsmeister AR, Brown ML, Malagelada JR, DiMagno EP,. 1989. Effect of ileal perfusion of carbohydrates and amylase inhibitor on gastrointestinal hormones and emptying. Gastroenterology 96: 377-387. (Pubitemid 19045268)
20. Joint WHO/FAO Expert Consultation. 2003. Diet, nutrition and the prevention of chronic diseases. Available at. Geneva, Switzerland: World Health Organization,.
21. Katz A, Nambi SS, Mather K, et al., 2000. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410. (Pubitemid 32269192)
22. Keränen AM, Savolainen MJ, Reponen AH, et al., 2009. The effect of eating behavior on weight loss and maintenance during a lifestyle intervention. Prev Med 49: 32-38.
23. Layer P, Carlson GL, DiMagno EP,. 1985. Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans. Gastroenterology 88: 1895-1902. (Pubitemid 15052303)
24. Matsui T, Ogunwande IA, Abesundara KJ, Matsumoto K,. 2006. Anti-hyperglycemic potential of natural products. Mini Rev Med Chem 6: 349-356.
25. Pusztai A, Bardocz S, Ewen SWB,. 2008. Use of plant lectins in bioscence and biomedicine. Front Biosci 13: 1130-1340.
26. Pusztai A, Grant G, Buchan WC, Bardocz S, de Carvalho AF, Ewen SW,. 1998. Lipid accumulation in obese Zucker rats is reduced by inclusion of raw kidney bean (Phaseolus vulgaris) in the diet. Br J Nutr 79: 213-221. (Pubitemid 28081872)
27. Steer RA, Ball R, Ranieri WF, Beck AT,. 1999. Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients. J Clin Psychol 55: 117-128. (Pubitemid 29044746)
28. Stunkard AJ, Messick S,. 1985. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 29: 71-83. (Pubitemid 15134378)
29. Tormo MA, Gil-Exojo I, Romero de Tejada A, Campillo JE,. 2006. White bean amylase inhibitor administered orally reduces glycaemia in type 2 diabetic rats. Br J Nutr 96: 539-544.
30. Udani J, Singh BB,. 2007. Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract. Altern Ther Health Med 13: 32-37. (Pubitemid 351299280)